None listed
Conditions
Brief summary
Despite the public health recommendation to consume 30g of nuts per day, there is limited data investigating whether the recommended amount of nuts is considered acceptable to the consumer. One study reported that consuming the recommended 30 grams per day of nuts was found to be achievable and acceptable. The study population used in this research was largely European, therefore whether the results can be extrapolated to other ethics groups e.g. Maori, is unknown. In addition to measuring the acceptability of nuts, it is of equal importance to investigate the health properties of nuts. To date, there are five human intervention trials that have investigated the effect of hazelnut supplementation on plasma cholesterol levels. As the study population in the previous studies was largely European, it is of interest to compare the health effects of regular nut consumption in European and other ethnic group, i.e. Maori. The NATINATI study therefore aims to compare the acceptability of hazelnuts and the effects on blood lipids, lipoproteins, apolipoproteins, hs-CRP, glucose and insulin after consuming 30g of hazelnuts per day for four weeks among matched (age within 1 year, sex, BMI for 2 BMI points) Maori and European participants.
Interventions
Sponsors
Study design
Eligibility
Inclusion criteria
The inclusion criteria are Maori and European males and females aged between 18 and 40 years of age. They should be in good health.
Exclusion criteria
The exclusion criteria are smokers. Pregnant or breastfeeding women. People who have asthma, food allergies or food aversions to nuts. People who have familial or secondary hyperlipidaemia or major chronic diseases such as cancer, heart disease or diabetes. People who are taking medication known to affect blood lipid levels.